Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2019	$ 29,000	$ 77,434,000	$ (67,257,000)	$ 10,206,000
Balance (in Shares) at Dec. 31, 2019	29,478,338
Common stock issued for directors fees		55,000		55,000
Common stock issued for directors fees (in Shares)	43,771
Costs related to issuance of stock		(145,000)		(145,000)
Issuance of Common Stock	$ 1,000	983,000		984,000
Issuance of Common Stock (in Shares)	419,597
Common Stock Issued for Convertible Notes		885,000		885,000
Common Stock Issued for Convertible Notes (in Shares)	590,243
Stock Compensation Expense		140,000		140,000
Net Income (Loss)			1,058,000	1,058,000
Balance at Mar. 31, 2020	$ 30,000	79,352,000	(66,199,000)	13,183,000
Balance (in Shares) at Mar. 31, 2020	30,531,949
Balance at Dec. 31, 2020	$ 32,000	81,238,000	(66,161,000)	15,109,000
Balance (in Shares) at Dec. 31, 2020	31,906,971
Common stock issued for directors fees		52,000		52,000
Common stock issued for directors fees (in Shares)	41,960
Stock Compensation Expense		157,000		157,000
Stock Options exercised
Stock Options exercised (in Shares)	51,224
Net Income (Loss)			(152,000)	(152,000)
Balance at Mar. 31, 2021	$ 32,000	$ 81,447,000	$ (66,313,000)	$ 15,166,000
Balance (in Shares) at Mar. 31, 2021	32,000,155